Cobalt (II) ions and nanoparticles induce macrophage retention by ROS-mediated down-regulation of RhoA expression by Xu, J et al.
Acta Biomaterialia 72 (2018) 434–446Contents lists available at ScienceDirect
Acta Biomaterialia
journal homepage: www.elsevier .com/locate /ac tabiomatFull length articleCobalt (II) ions and nanoparticles induce macrophage retention by
ROS-mediated down-regulation of RhoA expressionhttps://doi.org/10.1016/j.actbio.2018.03.054
1742-7061/ 2018 Acta Materialia Inc. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding authors.
E-mail addresses: lingfang.zeng@kcl.ac.uk (L. Zeng), m.m.knight@qmul.ac.uk
(M.M. Knight), j.shelton@qmul.ac.uk (J.C. Shelton).Jing Xu a, Junyao Yang b, Agata Nyga c,d, Mazdak Ehteramyan e, Ana Moraga e, Yuanhao Wu a,
Lingfang Zeng e,⇑, Martin M. Knight a,⇑, Julia C. Shelton a,⇑
a Institute of Bioengineering, School of Engineering and Materials Science, Queen Mary University of London, London, UK
bDepartment of Laboratory Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China
cDivision of Surgery and Interventional Sciences, University College London, London NW3 2QG, United Kingdom
d Institute for Bioengineering of Catalonia, 08028 Barcelona, Spain
eCardiovascular Division, Faculty of Life Science and Medicine, King’s College London, London SE5 9NU, United Kingdoma r t i c l e i n f o
Article history:
Received 18 November 2017
Received in revised form 15 March 2018
Accepted 30 March 2018
Available online 9 April 2018
Keywords:
Cobalt chromium
Nanoparticles
Wear debris
Macrophage
ROSa b s t r a c t
Histological assessments of synovial tissues from patients with failed CoCr alloy hip prostheses demon-
strate extensive infiltration and accumulation of macrophages, often loaded with large quantities of par-
ticulate debris. The resulting adverse reaction to metal debris (ARMD) frequently leads to early joint
revision. Inflammatory response starts with the recruitment of immune cells and requires the egress
of macrophages from the inflamed site for resolution of the reaction. Metal ions (Co2+ and Cr3+) have been
shown to stimulate the migration of T lymphocytes but their effects on macrophages motility are still
poorly understood. To elucidate this, we studied in vitro and in vivo macrophage migration during expo-
sure to cobalt and chromium ions and nanoparticles. We found that cobalt but not chromium signifi-
cantly reduces macrophage motility. This involves increase in cell spreading, formation of intracellular
podosome-type adhesion structures and enhanced cell adhesion to the extracellular matrix (ECM). The
formation of podosomes was also associated with the production and activation of matrix
metalloproteinase-9 (MMP9) and enhanced ECM degradation. We showed that these were driven by
the down-regulation of RhoA signalling through the generation of reactive oxygen species (ROS). These
novel findings reveal the key mechanisms driving the wear/corrosion metallic byproducts-induced
inflammatory response at non-toxic concentrations.
Statement of significance
Adverse tissue responses to metal wear and corrosion products from CoCr alloy implants remain a great
challenge to surgeons and patients. Macrophages are the key regulators of these adverse responses to the
ions and debris generated. We demonstrated that cobalt, rather than chromium, causes macrophage
retention by restructuring the cytoskeleton and inhibiting cell migration via ROS production that affects
Rho Family GTPase. This distinctive effect of cobalt on macrophage behaviour can help us understand the
pathogenesis of ARMD and the cellular response to cobalt based alloys, which provide useful information
for future implant design and biocompatibility testing.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Total hip arthroplasty (THA) restores mobility and improves the
quality of life in patients suffering from severe osteoarthritis or
femoral fractures. In 2015, 83,886 primary hip replacements wereconducted in the UK with 8,367 hip revision procedures performed
largely due to the aseptic loosening, pain, implant wear and
adverse reaction to metal debris (ARMD) [1]. It is expected that
these numbers will keep rising due to the ageing of population
and an increasing number of implanted prostheses.
Since the mid-1980 s, over one million metal-on-metal (MoM)
hip replacement prostheses, made from a cobalt chromium (CoCr)
alloy, have been implanted worldwide [2]. These were used for
joint replacements in younger, more active patients [3] due to
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generation metal-on-polyethylene (MoP) bearings or from the
fracture risk of a ceramic head. However, concerns for these
implants became increasingly prominent due to reports of ARMD
[4,5]. The metal wear debris and released ions (Co2+ and Cr3+),
which are widely generated in MoM bearings of hip implants, are
now also found in patients with MoP bearings due to the mechan-
ically assisted crevice corrosion of modular taper junctions, includ-
ing head–neck and neck-stem taper interfaces [5–8].
Wear and corrosion particles retrieved from tissues surround-
ing MoM devices have been shown to be predominantly in the
nanometer-size range [4,9]; the particles are generally smaller
than 50 nm (range 6–834 nm) with round or irregular morpholo-
gies. The wear particles have been generated in hip simulators to
have similar size distribution and morphology as recorded clini-
cally, however the in vitro studies so far have not established the
mechanism behind the adverse local response to these wear prod-
ucts, such as aseptic chronic inflammation and pseudotumour for-
mation [9–12], which is closely associated with pain and implant
failure.
Prolonged inflammation results in ARMD at the implant site.
First, wear particles and ionic corrosion products are detected
and phagocytosed mainly by the tissue-resident macrophages
[10] and if phagocytosed in a large number, these wear particles
can activate macrophages to release an array of cytokines and
chemokines to alarm circulating leucocytes [13]. Leukocytes infil-
trating the inflamed tissue, promote recruitment of neutrophils
or monocytes that differentiate locally into macrophages, and
potentiate the pro-inflammatory environment. At the same time,
the resolution of the inflammatory response occurs by removing
the dead neutrophils and the egress of inflammatory macrophages
from the inflamed tissue to the nearest opening of the draining
lymphatics [14]. The undesired response to a MoM implant are fre-
quently found to show soft tissue failure characterized by macro-
phage predominant infiltration with their massive intake of wear
particles [15]. Metal ions (Co2+ and Cr3+) have been shown to
enhance the migration of T lymphocytes independently of circulat-
ing cytokines or chemokines resulting in an accumulation of T lym-
phocytes in the periprosthetic tissues of some patients with CoCr-
based implants [16]. However, the mechanism behind the macro-
phage migration in the presence of both wear debris and ions is
largely unknown.
This study aims to reveal the mechanism regulating macro-
phage migration during exposure to cobalt and chromium com-
pounds, in order to understand the clinical manifestation of a
chronic inflammatory response. We have shown that cobalt, but
not chromium, affects the migration of macrophages through
ROS and RhoA signalling pathways.2. Materials and methods
2.1. Particles and ions
Cobalt and chromium nanoparticles were purchased from
American Elements (Los Angeles, CA, USA). Cobalt nanoparticles
(CoNPs) were composed of 90% cobalt and 10% cobalt (II,III) oxide
with a molecular weight of 58.93 and had a diameter of 2–60 nm
(data from the company). Chromium nanoparticles (CrNPs) were
in the form of chromium oxide (Cr2O3) nanoparticles with a diam-
eter of 10–30 nm (manufacturer data). Prior to use, the nanoparti-
cles were washed in 100% ethanol for sterilisation and resuspended
in sterile H20 at a concentration of 1 mg/ml using a sonicator
(pulsed mode, 3 min). Stock solutions (0.1 M) of Co2+ and Cr3+ ions
were freshly prepared by dissolving CoCl26H2O (99.5% purity;
Sigma Aldrich) and CrCl36H2O (98% purity; Sigma Aldrich) in ster-ile H20. These solutions were sterilized by filtration through 0.2
lm pore size sterile syringe filter (Merck Millipore). Stock solu-
tions of cobalt and chromium nanoparticles and ions were further
diluted in cell culture medium to achieve the desired
concentrations.2.2. Characterization of the cobalt and chromium nanoparticles
Transmission Electron Microscopy (TEM; JEOL JEM-2010, Japan)
was employed to observe the morphology of CoNPs and CrNPs as
shown in Fig. S1. CoNPs and CrNPs were suspended in pure ethanol
and a drop of particle suspension was placed onto the carbon
coated grid. The polydispersity index (PDI) and the surface charge
of cobalt and chromium nanoparticles in 1640 RPMI medium that
were employed in this study were analysed by Zetasizer (Malvern
Co., UK).2.3. Cell lines and culture preparation
2.3.1. Human U937 monocytic cell line
Cells from the U937 cell line (passage 6-25, donation from Dr
Akihisa Mitani, Imperial College London, UK) were cultured in
RPMI 1640 medium (ThermoFisher, USA) supplemented with 10%
FBS (Sigma, USA), 1.9 mM L-glutamine, 96 U/ml penicillin, 96 lg/
ml streptomycin, 19 mMHEPES buffer, in a humidified atmosphere
with 5% CO2 at 37 C. To induce differentiation into adherent
macrophage-like cells, cells were treated with 50 ng/ml PMA
(Phorbol 12-myristate 13-acetate, Sigma Aldrich) for 48 h and fol-
lowed by rest for a further 24 h in complete RPMI 1640 medium
prior to further experiments.2.3.2. Isolation and differentiation of bone marrow-derived
macrophages
Bone marrow-derived macrophages (BMDMs) were harvested,
pooled and differentiated according to established standard proto-
cols [17]. To review briefly, femurs and tibiae were obtained from 8
of 6–12-week-old C57BL/6 mice. All mice were cared for according
to the UK Animal Scientific Procedures Act (1986) and by the Insti-
tutional Committee for Use and Care of Laboratory Animals. Exper-
iments were performed under the UK Home Office Personal licence
number I56EDA266 and the groups UK Home Office Project Licence
number 70/7266. Bone marrow was flushed from femurs and tib-
iae and bone marrow cells were collected and differentiated in
RPMI-1640 complete medium containing macrophage colony-
stimulating factor (M-CSF, 50 ng/ml, R&D Systems, Minneapolis,
MN, USA) for 7 days.2.4. Cytotoxicity assay
A colourimetric assay, MTS, was performed to assess the effect
of cobalt and chromium nanoparticles and ions on macrophage
viability using the CellTiter 96 Aqueous One Solution Cell Prolifer-
ation Assay (Promega, Southampton, UK). Cells (U937 macro-
phages or BMDMs) were seeded at a concentration of 5  104 in
96-well plates. For vehicle control, cells were stimulated with com-
plete RMPI medium. After incubation for 6 and 24 h, medium was
aspirated and 100 ll of serum-free RPMI medium containing 10%
MTS reagent was added to each well. Plates were subsequently
incubated for 3 h at 37 C and the absorbance was read at 490
nm using an Infinite F50 plate reader (Tecan, Switzerland). Five
replicates of each exposure were tested and the entire assay was
repeated for three separate experiments. The cell viability was
determined as a percentage of control cell viability.
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2.5.1. Single cell motility monitoring
Macrophage migratory ability was first investigated using live
cell imaging. Inverted microscope (Lumascope 720, Etaluma,
USA) connected to a cell culture incubator was used for live cell
imaging to visualise macrophage migration. Time-lapse images of
migrating U937 macrophages at a seeded density of 2  104
cells/cm2 in a 24-well plate were collected after 12 h incubation
with Co2+ (200 mM), Cr3+ (400 mM), CoNPs (100 mM) or CrNPs
(400 mM). The application of different concentrations of Co2+,
Cr3+, CoNPs and CrNPs, Table 1, was based on the highest concen-
tration that could be delivered whilst maintaining high cell viabil-
ity, following cell viability tests shown in Fig. S2.
Images were captured every 5 min for 6 h. Migratory properties
of individual cells identified from the time-lapse images were then
analysed using ImageJ software (n = 25 cells/condition).2.5.2. Transwell cell migration assay
Cell migration was also investigated using 6.5 mm Transwell
chambers with 8 lm pores (Costar, Corning, NY, USA). Briefly, 2
 105 harvested U937 macrophages or BMDMs in serum free RPMI
1640 medium were added to the upper chamber of the insert. The
lower chamber was filled with 600 ml RPMI 1640 mediumwith 10%
FBS to encourage cell migration down the FBS chemotactic gradi-
ent. Cells migration was analysed over a 6-hour period in the pres-
ence of Co2+ or Cr3+ that was added to both the upper and lower
well at the required concentration or following 2-hour pretreat-
ment with CoNPs or CrNPs (Table 1). After 6 h treatment, cells
remaining on the membrane were fixed with 4% paraformaldehyde
(Sigma, USA), stained with crystal violet (Sigma, USA) and counted.2.5.3. In vivo macrophage migration assay and FACS (flow cytometry)
analysis
To demonstrate the validity of the in vitro studies, the in vivo
effect of cobalt ions on mouse macrophage migration was studied.
20 wt C57BL/6 mice were first injected intraperitoneally with 1 ml
of 4% thioglycollate (Sigma, USA) to recruit macrophages into the
peritoneal cavity. After 4 days, the mice were injected intraperi-
toneally with 5 mg of CoNPs (10 mice) or PBS (10 control mice).
After 12 h, 5 mice from each group were injected with LPS (250
ll; 5 lg/ml) intraperitoneally to induce macrophages migration
towards the regional lymph nodes; the remaining 5 mice from
each group were injected intraperitoneally with PBS (250 ll) as
blank control. After 4 h, the peritoneal cells were harvested by
lavage and counted. The macrophages in the lavage were quanti-
fied by flow cytometry. Cell suspensions were pre-incubated with
anti–CD16/CD32 mAb to block FccRII/III receptors (BD Pharmin-
gen) on ice for 15 min. After washing the suspension, cells were
stained with PE/Cy5 anti-mouse CD11b antibody (Abcam, UK)
and FITC anti-mouse F4/80 antibody (Abcam, UK). Stained cells
were washed and re-suspended in 200 ll of PBS and analysed
using a flow cytometer (BD ACCURI C6) and FlowJo software
(TreeStar).Table 1
Concentration of cobalt and chromium applied during the migration tests.
Treatment Cell type
U937 macrophages BMDMs
Co2+ 200 mM 50 mM
Cr3+ 400 mM 200 mM
CoNPs 100 mM 20 mM
CrNPs 400 mM 200 mM2.6. Scanning electron microscope (SEM) analysis
U937 macrophages on the coverslips were fixed in 2.5% glu-
taraldehyde (Sigma, USA) for 2 h and dehydrated in graded ethanol
(50%, 70%, 80%, 90%, 95%, and 100%; 10 min for each). The samples
were transferred to critical-point drying with hexamethyldisi-
lazane (Sigma, USA) then coated with a 5 nm thick layer of gold–
palladium alloy. The SEM images were obtained with a scanning
electron microscope (FEI Quanta 200) at a low voltage (1 kV).
2.7. Immunofluorescence confocal and super resolution microscopy
Treated cells (U937 macrophages or BMDMs) were fixed with
4% paraformaldehyde (Sigma, USA) and washed and permeabilized
with 0.5% Triton X-100 and rinsed 3 times with PBS. Nonspecific
binding sites were blocked by adding PBS with 1% BSA. The adhe-
sion protein, vinculin, was labelled by incubation at 4 C, overnight
with mouse monoclonal anti-vinculin primary antibody, clone
hVIN-1 (1:400, Sigma, USA). Cells were then washed and incubated
for 1 h at room temperature in Alexa 488 conjugated anti-Mouse
IgG as Secondary Antibody (1:1000, Invitrogen, USA). In separate
samples, cellular a-tubulin and acetylated a-tubulin were labelled
using rabbit polyclonal anti-a tubulin antibody (1:200, Abcam, UK)
and mouse anti-acetylated tubulin, clone 611B-1 (1:2000; Sigma-
Aldrich, USA) respectively with Alexa 488 secondary antibodies
as above.
To simultaneously label the F-actin, the samples were incu-
bated for 30 mins with 200 ll of rhodamine-conjugated phalloidin
(Molecular Probes, USA) in a humidified chamber at room temper-
ature in the dark. Cell nuclei were stained by incubation with 5 lg/
ml DAPI (Dojindo, USA) followed by two PBS rinses. Slides were
then visualized with a fluorescence microscope (SP2, Leica, Ger-
many) with 63 objective. Slides were also imaged on a micro-
scope (710 ELYRA PS.1, Zeiss, Germany) with a 63/1.4NA
objective for structural illumination microscopy.
2.8. Cell adhesion assay
U937 macrophages were seeded at a concentration of 2  105
cells/well into a 24-well plastic cell culture plate coated with 2%
gelatin and treated with 100 mM, 200 mM or 300 mM Co2+. After
30 min of incubation, cell culture medium in each well were aspi-
rated and gently rinsed 2 times with warm PBS. Adherent cells of
were then imaged (10 fields of each well were randomly selected)
with an inverted microscope (DCF420, Leica, Germany) and
counted.
2.9. Proteolytic activity measurement
2.9.1. In vitro ECM degradation assay
U937 macrophages were seeded onto coverslips coated with
FITC-conjugated gelatin, as part of an in vitro ECM degradation
assay, as previously described [18]. Briefly, glass coverslips were
coated with 0.2 mg/ml FITC-gelatin (Molecular Probes, USA) in
PBS and fixed with 0.5% glutaraldehyde, washed six times with
PBS, then washed once with 70% ethanol/PBS and once with med-
ium. U937 macrophages (1  105/well) were plated onto the cover-
slips and incubated at 37 C in the presence of Co2+ (200 mM),
CoNPs (100 mM), Cr3+ (400 mM) or CrNPs (400 mM) for 24 h, then
fixed, processed for F-actin staining with rhodamine-conjugated
phalloidin, and observed as described above. The coverslips were
examined using a confocal microscope (SP2, Leica, Germany) and
the total area that was degraded was measured using ImageJ soft-
ware [18]. The matrix degradation index was calculated as the
ratio between the area of gelatin matrix degraded by treated cells
to that degraded by untreated cells.
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Conditioned media collected from cells treated by cobalt ions
(100 mM, 200 mM, 300 mM) and nanoparticles (20 mM, 50 mM and
100 mM) for 24 h were used for gelatin zymography. The super-
natants were subjected to electrophoresis in an 8% SDS-PAGE gel
co-polymerized with gelatin (1 mg/ml, Sigma, USA). The gelati-
nolytic activities were detected as transparent bands against the
background of Coomassie Brilliant Blue-stained gelatin and quanti-
fied using ImageJ software.
2.10. ROS measurements
ROS formation was measured using 5-(and 6-)-chloromethyl-2
070-dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Life tech-
nologies, USA). Cells were cultured in black 96-well plates with a
clear bottom. After exposure to cobalt, the supernatant was
removed and cells were briefly washed with warmed PBS. CM-
H2DCFDA was dissolved in anhydrous DMSO to a final concentra-
tion of 1 mM and diluted further in Hank’s balanced salt solution
(HBSS, ThermoFisher, USA). Cells were exposed to 1 lM CM-
H2DCFDA for 30 min at 37 C in the dark. Fluorescence was read
at an excitation of 485/20 nm with emission 528/20 nm using a
microplate reader (Synergy HT Multi-Mode, Biotek, USA).
2.11. Protein extraction and immunoblotting
All lysis buffers were supplemented with 1% protease inhibitor
(Sigma Aldrich, USA). Protein extracts were resolved using gradient
precast SDS – polyacrylamide gel electrophoresis (Biorad Laborato-
ries Inc, USA), and then electro-transferred onto a nitrocellulose
membrane by using Trans-Blot TurboTM Transfer System (Biorad
Laboratories Inc, USA) for immunoblot analysis. Antibody probing
was done as per manufacturers’ instructions Antibodies used
include anti-RhoA antibody (1:1000, Abcam, UK), anti-CDC42 anti-
body (1:1000, Abcam, UK), anti-Rac1 antibody (1:1000 Abcam,
UK), anti-phospho-MYPT1 (Thr696) antibody (1:1000, Cell
Signaling Technology, USA), anti-myosin light chain (phospho
S20) antibody (1:1000, Abcam, UK), anti-GAPDH antibody
(1:2000, Abcam, UK). Secondary antibodies either IRDye 800CW
Goat anti-Mouse IgG (LI-COR, USA) or IRDye 800CW Goat anti-
Rabbit IgG (LI-COR, USA) were used with dilution of 1:15000.
Specific protein bands were detected using Odyssey CLx Imaging
System (LI-COR, USA).
2.12. Data analysis
All data are expressed as the mean ± SEM from independent
repeat experiments (N = 3) unless otherwise stated. The number
of repeat measurement per experiment (n) is indicated in each fig-
ure. All statistical differences were analysed with one-way ANOVA
or Kruskal-Wallis test with Dunn’s Multiple Comparison Test
unless otherwise stated (SPSS Inc., Chicago, IL, USA). A value of P
< 0.05 was considered statistically significant.3. Results
3.1. Cobalt (II) ions and nanoparticles inhibit U937 macrophage
random migration
To directly measure the impact of cobalt and chromium on
macrophage motility in vitro, we first performed time-lapse imag-
ing of U937 macrophages after 12 h of cobalt or chromium treat-
ment using non-cytotoxic concentrations (Supplementary
Fig. S2). Fig. 1A–E shows the migration paths for 25 individual cells
in each treatment group. The total path length of cells treated withCo2+ and CoNPs were significantly shorter than those for untreated
control cells (P < 0.001, Fig. 1F). Treatment with Cr3+ or CrNPs had
no significant effect on macrophage migration.
3.2. Cobalt inhibits U937 macrophages and BMDMs transmigration
Using transwell migration assay we confirmed the results
observed during random cell migration (Fig. 1). The ability of
U937 macrophages to migrate through the porous transwell mem-
brane was significantly impaired by pre-treatment with either Co2+
or CoNPs (Fig. 2). Exposure to Co2+ and CoNPs, reduced the number
of transmigrating U937 macrophages by approximately 62% and
55%, respectively, whilst for BMDMs, the corresponding reductions
in migration were approximately 45% and 53%, respectively
(Fig. 2B). Incubation with Cr3+ and CrNPs had no statistically signif-
icant effect on the cell migration relative to untreated controls for
either U937 macrophages or BMDMs.
3.3. CoNPs inhibit macrophage migration in vivo
To determine whether cobalt affects macrophage migration
in vivo, we quantified the number of macrophages in the mouse
peritoneal cavity before and after LPS stimulation in mice with or
without cobalt pre-treatment. As neither Cr3+ nor CrNPs showed
any significant effect on macrophage migration in vitro, only cobalt
exposure was examined during the in vivo study. Mice were
injected with cobalt nanoparticles to mimic the generated cobalt
in vivo dissolution products. Harvested peritoneal macrophages
were identified by a flow cytometry gating strategy according to
their size and granularity (Fig. 3A), CD11b and F4/80 surface mar-
ker expression (Fig. 3B). In mice not stimulated with LPS, the CoNPs
pre-treatment had no significant effect on the number of peri-
toneal macrophages compared with control group (PBS only). After
LPS stimulation, a marked efflux of peritoneal macrophages (by
approximately 60%, Fig. 3C) from the cavity of control mice (PBS
only) was observed, consistent with previously published work
[19]. In mice pre-treated with CoNPs, the LPS stimulation had no
significant effect in inducing macrophages efflux, with the number
of macrophages remained at similar levels to the CoNPs group
without LPS treatment, which indicated that the ability of macro-
phages to migrate out of the peritoneal cavity was significantly
inhibited by CoNPs.
3.4. Cobalt modulates microtubule acetylation in U937 macrophages
To initiate cell migration, internal forces developed by the actin
cytoskeleton are transmitted through cell-substrate adhesion sites
while a dynamic turnover of adhesion complexes occurs [20]. Dis-
ruption in the cell migration indicates either an alteration in this
force transmission or changes in the cell adhesion strength. Uptake
of metal particles can impede the force balance between the micro-
tubule (MT) and F-actin by inhibiting MT polymerization in epithe-
lial cells [21]. Therefore, we investigated whether microtubule or
cytoskeletal impairment causes the inhibition of macrophage
migration. The MT structure of the control and treated cells are
shown in Fig. 4A. Both Co2+ and CoNPs induced a significant
increase in U937 macrophage alpha tubulin acetylation, one of
the basic components for MT biopolymer [22], confirmed by
immunofluorescence staining (Fig. 4A and B) and Western Blot
analysis (Fig. 4C and D). In contrast, chromium ions had no signif-
icant effect on the MT organisation or acetylation while CrNPs
slightly reduced the MT acetylation, although it was not statisti-
cally significant. We also investigated the effect of an inhibitor of
a member of the histone deacetylase family, HDAC6, which regu-
lates MT-dependent cell motility via mediating tubulin deacetyla-
tion [23]. HDAC6 overexpression induces a global deacetylation of
Fig. 1. Cobalt ions and nanoparticles reduce U937 macrophage random migration. (A-E): Detailed migration trajectories of cells (n = 25) over a 6-hour period following
treatment with cobalt or chromium. Individual tracks were transposed so that each of the cells started at the same origin. (F) Net cell migration length for each treatment with
values indicating mean + SEM for N = 3 experiments (n = 25 cells/condition/experiment). Statistical differences from untreated control are based on one-way ANOVA with
Bonferroni post-test; ***P < 0.001.
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U937 cell were treated with a HDAC6 inhibitor, Tubastatin A (5
mM), a hyperacetylation of tubulin was observed (Fig. 4A), showing
much higher effect than the cobalt treatment. Tubastatin A also
significantly reduced the number of migrating cells in a transwell
migration assay, however only partially replicating the effect of
cobalt treatment (Fig. 4E). This suggests that cobalt-mediated
tubulin acetylation in macrophages does not play the critical role
in the downregulation of cell migration.
3.5. Cobalt ions and nanoparticles promote macrophage spreading and
podosome formation, which are associated with increased cell
adhesion
Macrophage migration involves remodelling of the actin
cytoskeleton associated with cell spreading, disassembly of exist-
ing focal adhesions, and formation of new cell-matrix interactions.
SEM imaging revealed that both Co2+ and CoNPs significantly
increased U937 macrophage spreading with increase in lamellipo-
dia protrusions around the cell periphery (Fig. 5A). In this case,
CoNP-treatment had a significantly greater effect than Co2+ treat-
ment (Fig. 5B). U937 macrophages expressed characteristic
podosome-like punctate adhesion structures, characterised by an
actin-rich core surrounded by vinculin adhesion proteins
(Fig. 5C). Treatment with either Co2+ or CoNPs significantly
increased both the podosome number (Fig. 5D) and density within
individual cells (Fig. 5E). Cobalt also significantly increased the
percentages of cells forming podosomes in BMDMs (Fig. S4). Exces-
sive formation of the adhesion complex can result in a strong
anchorage of cells to the underlying substrate, thereby inhibiting
cell migration [24]. Hence, we examined whether changes in
macrophage morphology and podosome formation during cobalttreatment were associated with alterations in cell adhesion.
U937 cells exposed to Co2+ showed an increased cell adhesion to
the ECM in a concentration-dependent manner (Fig. 5F and G). This
effect of Co2+ was not evident on BMDMs (data not shown), possi-
bly due to differences in the speed of the cell adhesion to the
matrix. Collectively, these results indicate that the cobalt-
induced inhibition of macrophage migration is associated with
cytoskeletal reorganisation, podosomes formation and increased
cell adhesion.
3.6. Cobalt-induced podosome formation in U937 macrophages
stimulates ECM degradation
Podosomes promote adhesion to the substrate and degrade the
components of the ECM. To determine whether cobalt-induced
podosomes are able to locally degrade the ECM, we performed an
in vitro matrix degradation assay based on loss of FITC-
conjugated gelatin. Macrophages induced localised degradation
as shown by dark areas in the fluorescent-tagged gelatin matrix
(indicated by arrows in Fig. 6A). The degradation of gelatin was clo-
sely associated with cells expressing podosomes and in some cases,
the podosomes were located directly over the degraded matrix
(Fig. 6A). Both Co2+ and CoNPs promoted matrix degradation
(Fig. 6B), with associated statistically significant differences in
matrix degradation index (Fig. 6C). Treatment with Cr3+ and CrNPs
had no significant effect on the ECM degradation (Fig. 6B).
The matrix degradation by podosomes involves the recruitment
and activation of matrix metalloproteinases (MMPs) [25]. Using a
zymography assay we measured the release and activation of
MMPs. We observed release of MMP9 (band at a molecular weight
of 82–92 kDa) after cobalt treatment (Fig. 6D). Additionally, a
lower band of 82 kDa molecular weight was observed indicating
Fig. 2. Cobalt ions and nanoparticles reduce transmigration of U937 macrophages and BMDMs. (A) Representative images of migrated U937 macrophages and BMDMs
treated by Co2+, CoNPs, Cr3+ and CrNPs (Scale bar = 100 mm). (B) Quantifications of the migration assay based on three independent experiments. Values represent mean ±
SEM. N = 3. For each experiment, 10 random fields were imaged for each treatment (n = 10). Statistically significant differences are indicated relative to untreated control
based on one-way ANOVA with Bonferroni post-test; ***P < 0.001.
Fig. 3. Macrophage migration in vivo is inhibited by CoNPs. Representative FACS analysis images showing the gating strategy to identify the peritoneal macrophages based on
(A) cell size and granularity, (B) CD11b and F4/80 surface markers expression. (C) Number of harvested macrophages from treated mice from each group, with data
normalised to PBS control group (mice injected with PBS twice). Statistically significant differences were determined by one-way ANOVA and Bonferroni’s multiple
comparison test (n = 5 mice per treatment, **indicates difference from PBS control (PBS only) P  0.01; # indicates difference between CoNPs and PBS treatment with LPS,
P < 0.05).
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induced pro-MMP9 release was not concentration-dependent,
while the formation of active MMP9 was (Fig. 6E). Cobalt exposure
had no significant effect on MMP2 release. Immunofluorescent
staining revealed that intracellular MMP9 frequently co-localised
with cobalt-induced podosomes (Fig. S3). In line with the results
shown in Fig. 6B, Cr3+ and CrNPs did not cause any significant
change in the release of MMP2, pro-MMP9 nor the active form of
MMP9 (data not shown).3.7. Inhibition of macrophage migration in the presence of cobalt was
associated with ROS production and its down-regulation of RhoA
expression.
Heavy metal ions and nanoparticles can provoke cellular stress,
which may lead to alterations in cellular structure and function,
and potentially loss of cell viability [26]. Both Co2+ and CoNPs
induced ROS in a concentration-depended manner in U937 macro-
phages, and we showed that this also occurs at non-cytotoxic
Fig. 4. Cobalt-induced hyper-acetylation of tubulin and its effect on macrophage migration. (A) Representative immunofluorescence confocal images of U937 macrophages
treated with Co2+, CoNPs, Cr3+, CrNPs and Tubastatin A for 24 h. Cells were stained for acetylated a-tubulin (red) and a-tubulin (green). Scale bar represents 20 mm. Integrated
fluorescent signal intensity for acetylated and non-acetylated tubulin in each cell was quantified and shown in (B) n = 25; values represent mean + SEM; *P  0.05; **P  0.01;
N = 3. (C) Western blots for acetylated a-tubulin and a-tubulin for cells treated with cobalt, chromium, Tubastatin A for 24 h and (D) the corresponding quantification
demonstrating increased total a-tubulin acetylation. Values represent mean + SEM; */*** indicate difference from control, P  0.05/P  0.001; ### indicates difference between
Co2+ and Tubastatin A, P  0.001; N = 3. (E) Increased tubulin acetylation with Tubastatin A significantly reduced macrophage transwell migration. Values represent mean +
SEM; *P < 0.05, **P  0.01; N = 3 experiments, n = 10 fields of view per experiment. All statistically significant differences were determined by one-way ANOVA and
Bonferroni’s multiple comparison test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
440 J. Xu et al. / Acta Biomaterialia 72 (2018) 434–446concentrations (Fig. 7A). The maximum increase in ROS production
of approximately 90% compared to unstimulated cells, occurred
within the first 30 min. This significant increase persisted for 4 h
of treatment but decreased after 6 h. Exposure to CoNPs at 100–1
50 mM induced a transient upregulation in ROS measured at 2 h,
with an increase of approximately 75% at 150 mM (Fig. 7B). Co-
treatment with ROS scavenger and antioxidant, NAC (N-acetyl-L-
cysteine), abolished the cobalt-induced ROS production in cells
(Fig. 7A and B). We next tested whether ROS generation was
responsible for the cobalt-induced podosome formation and the
consequent inhibition of U937 macrophage migration. Co-
treatment of Co2+-treated cells with NAC resulted in a reduction
in the cobalt-induced podosome formation (Fig. 7C and D) and a
significant increase in Co2+-treated macrophage transmigration
(Fig. 7E). As mitochondria and NADPH oxidases are the main
sources of cellular ROS, we also tested the effect of a NADPH oxi-
dase inhibitor apocynin (5 lM, 10 lM and 50 lM). However, apoc-
ynin was not able to inhibit cobalt-mediated ROS generation nor to
restore macrophage migration (data not shown), which suggested
that cobalt-mediated ROS increases are mainly mitochondria-
derived.
Actin organisation and podosome turnover are tightly regulated
by the Rho GTPase, such as RhoA, Rac1 and Cdc42, whose activity is
determined by their guanine nucleotide-bound state [27]. To
determine if cobalt-induced ROS acts as an upstream regulator toactivate Rho GTPases, we investigated the expression of RhoA,
Cdc42 and Rac1 after U937 macrophages were treated by Co2+
(200 mM) and CoNPs (100 mM) for 24 h. As shown in Fig. 7F and
G, cobalt did not affect the Rac1 and Cdc42 levels, but caused
decreased RhoA expression indicating that Co2+ and CoNPs nega-
tively regulate RhoA signalling. This was further confirmed by
down-regulation of the downstream proteins of RhoA signalling,
such as pMLC (phospho-myosin Light Chain) and pMYPT
(phospho-myosin-binding subunit of myosin phosphatase).
In addition, the treatment of macrophages with the RhoA-
specific inhibitor C3 Transferase (2 lg/ml) and RhoA/ROCK1
pathway inhibitor Y-27632 (20 mM) also led to intensive cell
spreading and increased podosome formation (Fig. 7H) as
observed in cobalt-treated cells. Accordingly, the migration of
U937 macrophages were also significantly impaired when RhoA
signalling was inhibited by inhibitor C3 Transferase and Y-
27632 (Fig. 7H and I). Furthermore, the reduced expression of
RhoA level caused by Co2+ and CoNPs was significantly reversed
by using the NAC (Fig. 7 J and K), which has showed to suppress
the cobalt-induced ROS generation and be capable of partially
restore the migration ability of U937 macrophages. These data
suggest that cobalt-induced ROS production lies upstream of
the RhoA signalling and down-regulation of RhoA expression
results in remodelling of macrophage cytoskeleton and impaired
migration.
Fig. 5. Reduced macrophage migration induced by cobalt is associated with increased cell spreading and podosome formation and cell adhesion to extracellular matrix. (A)
Representative SEM images of U937 macrophages incubated for 12 h with Co2+ (200 mM), CoNPs (100 mM), Cr3+ (400 mM) or CrNPs (400 mM) and untreated control. Scale bar
indicates 100 mm. (B) Quantification of projected cell area for each treatment. Values represent mean + SEM for N = 3 separate experiments with n = 150 cells per experiment.
Statistically significant differences from untreated control determined by one-way ANOVA and Bonferroni’s multiple comparison test. ***P  0.001. (C) Representative
confocal microscopy images showing appearance of punctate podosome adhesion structures consisting of actin core (red) and surrounded by vinculin (green) in U937
macrophages following treatment with cobalt or chromium as described in (A). Scale bar indicates 10 mm. Associated quantification of (D) podosome number/cell and (E)
podosome density. n = 150 cells for each group. Data with median shown from one representative experiment out of three; significance was determined by Kruskal-Wallis
test and Dunn’s Multiple Comparison Test. ***P  0.001; N = 3. (F) Representative brightfield fields of view images showing that cobalt increased cell adhesion to ECM in a
dose-dependent manner, where the scale bar indicates 100 mm, as quantified in (G) showing significantly increased numbers of adherent cells per field of view at 200 lM and
300 lM. Data indicates mean + SEM for N = 3 with n = 10 fields of view per experiment. Statistical significance based on one way ANOVA and Bonferroni’s multiple
comparison test; *P  0.05, **P  0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Macrophages play an essential role in surveillance and
coordination of the inflammatory cascade associated with implant
stability. The production of CoCr alloy wear debris leads tophagocytosis of the particles by macrophages [28]. This metal deb-
ris with associated ions activate the monocyte/macrophage lineage
to release a variety of mediators, such as free radicals, nitric oxide,
tumour necrosis factor-a (TNF-a), interleukin-1 b (IL-1 b), prosta-
glandin E2 (PGE2) and IL-6 [29–32], which are influenced by the
Fig. 6. Enhanced ECM degradation induced by cobalt is associated with the release and activation of MMP9, which co-localizes with podosomes. (A) Representative
fluorescence microscopy image showing FITC-conjugated gelatin (green) degraded by U937 macrophages counter stained for F-actin (red) podosomes. Associated
fluorescence intensity measurements demonstrate the co-localization of areas of gelatin degradation and the F-actin podosomes. Scale bar indicates 10 mm. (B)
Representative images showing FITC-conjugated gelatin degradation following 24 h treatment with Co2+ (200 mM), CoNPs (100 mM), Cr3+ (400 mM) or CrNPs (400 mM) and
untreated control. Scale bar indicates 20 mm. (C) Associated measurements of degradation area quantified as degradation index normalized to control group show
significantly increased degradation following cobalt treatments. Values represent mean + SEM for N = 3 with n = 10 fields of view per experiment. (D) Zymography gels
showing the release and activation of MMP9 by U937 cells due to cobalt treatment. (E) Quantification of the formation of pro-MMP9, active MMP9 and MMP2 based on
gelatin zymography results, values represent mean + SEM for N = 5. All statistically significant differences between different groups and control were determined by one way
ANOVA and Bonferroni’s multiple comparison test; *P  0.05, **P  0.01, ***P  0.001. (For interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
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ions can sensitize the immune system by inducing a delayed type
IV hypersensitivity response [33]. Moreover, CoCr nanoparticles
have been shown to be able to induce DNA damage and chromoso-
mal aberration across cellular barriers [34]. In our study we eluci-
dated the mechanism of altered macrophage behaviour by metal
ions and particles at non-cytotoxic concentrations.
We used a combined in vitro and in vivo approach to examine
the differential response of macrophages to cobalt and chromium
ions and nanoparticles. Using a range of techniques, we have
demonstrated for the first time that non-toxic levels of cobalt sig-
nificantly reduce macrophage migration due to impaired egress
capacity of macrophages. We have also further elucidated the
underpinning molecular mechanism, which involves down-
regulation of RhoA expression through induced ROS production.
These findings provide new mechanistic explanation of the exten-
sive clinical failures of orthopaedic implants manufactured from
CoCr alloys, which are associated with retention of the macro-
phages and consequent prolonged and unrestrained inflammatoryreactions that could lead to implant failure ultimately. In particu-
lar, the present in vitro results revealed that relatively low levels
of both Co2+ ions (100 lM) and CoNPs (200 lM) markedly inhibit
the random migration and chemotaxis of both U937 macrophages
and murine bone marrow derived macrophages (BMDM), while
Cr3+ and CrNPs demonstrated no significant effect (Figs. 1 and 2).
This was confirmed in an in vivo peritoneal macrophage efflux
experiment, where we found that CoNPs inhibit the macrophage
emigration from the cavity triggered by LPS (Fig. 3).
The mechanisms of the particulate-mediated inflammatory
response associated with the imbalance in tissue homeostasis
remain unclear, although a retention of macrophages within
periprosthetic tissues is often reported [35,36]. We report, for the
first time, that the retention of macrophages during cobalt expo-
sure is associated with an increase in both podosome formation
and cell spreading (Fig. 5). These morphological and structural
changes associated with macrophage retention are dependent on
ROS formation (Fig. 7). Additionally, during increased podosome
formation, an increase in MMP9 production occurs, resulting in a
Fig. 7. Cobalt stimulates ROS production which stimulates podosome formation and impedes macrophage migration. (A, B) Dose and time dependent ROS production
induced by Co2+ and CoNPs; values represent mean + SEM from N = 3 separate experiments. Statistically significant differences determined by one-way ANOVA and
Bonferroni’s multiple comparison test. (**P  0.01; ***P  0.001, (***indicates significant upregulation for all of the three concentrations). (C) Fluorescence images showing that
the ROS inhibitor, NAC (5 mM, 12 h) prevents Co2+ induced upregulation of podosome formation as shown by F-actin labelling with phalloidin and quantified in (D), data with
median shown from one representative experiment out of three; significance was determined by Mann-Whitney test. ***P  0.001; N = 3. (E) Suppression of U937 macrophage
transmigration is rescued by treatment with NAC. Data indicates the mean + SEM for number of migrated cells per field of view from 3 separate experiments, N = 3, with
n = 10 fields of view per experiment (#P  0.05, ##/**P  0.01; ###/***P  0.001). Scale bars represents 10 mm. (F) Western blots results for untreated cell and cells treated with
Co2+ (200 mM) and CoNPs (100 mM) for 24 h. (G) The corresponding quantification demonstrating decreased RhoA expression. Values represent mean + SEM; ***indicate
difference from control, P < 0.001; N = 3. (H) Representative images showing the effects of inhibitor C3 Transferase and Y-27632 on U937 macrophage cytoskeleton
organization and migration. (I) Quantification of the effects of C3 Transferase and Y-27632 on U937 macrophage organization. Values represent mean ± SEM. N = 3. For each
experiment, 10 random fields were imaged for each treatment (n = 10). **P < 0.01. (J) Western blots results showing RhoA level reduced by Co2+ and CoNPs could be partially
restored by inhibition of ROS with NAC (5 mM). (K) The corresponding quantification of cellular RhoA level with treatment by Co2+, CoNPs and NAC. Values represent
mean + SEM; **indicate difference from control, P < 0.01; N = 3. Scale bars represents 10 mm in (C) and (H).
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dependant manner (Fig. 6). This mechanism reducing macrophage
migration in response to Co2+ ions and CoNPs provide a new
insight into the tissue responses and subsequent implant failure
assocaited with CoCr alloys.
The mechanism of cell migration is controlled by a co-ordinated
turnover of the actin and microtubule cytoskeletal network [37].
Migration is regulated by actin polymerization with actin/myosin
interactions forming contractile forces to retract the cell, while
microtubules specify migration directionality [38]. When studying
the effect of cobalt and chromium on these critical components of
the cell migration machinery, we observed a slightly decrease in
the acetylation of a-tubulin in response to CrNPs, without affecting
cell motility (Figs. 4 and 2). In contrast, cobalt increased a-tubulin
acetylation while inhibiting cell migration. To test whether
increased acetylation initiates the inhibition of macrophage migra-
tion, we induced tubulin acetylation with Tubastatin A, a potent
HDAC6 inhibitor [22]. Tubastatin A treatment resulted in higher
levels of a-tubulin acetylation than cobalt, and a reduction in
macrophage migration, but to a smaller extend than cobalt
(Fig. 4E). These results indicate either a non-specificity of Tubas-
tatin A or that the migration response to cobalt involves additional
mechanisms.
Apart from tubulin modifications, we found that cobalt induced
alteration in macrophage morphology by enhancing cell spreading
and an increase in the number and density of podosomes (Fig. 5A
and D). Both cell spreading and podosomes formation involve the
deformation of a cell membrane and the strengthening of cell–sub-
strate attachment [39,40]. Podosome-type adhesions are rich in
vinculin and other types of adhesion proteins, and regulate cell
adhesion to the ECM [40]. Cell spreading and short-lived podosome
formations with their adhesion structures are associated with
enhanced macrophage migration and invasion [27]. When either
process is uncontrolled, cell migration can be hindered [41]. For
example, the inflammatory mediator PGE2 promotes macrophage
migration in response to chemotactic signals, but at high doses,
it reduces macrophage chemotaxis by enhancing cell-substratum
adhesion [24]. In our study, we confirmed that the non-toxic con-
centrations of Co2+ led to a concentration-dependent increase in
cell adhesion to the ECM substrate (Fig. 5F and G). These results
suggest that the reduction in macrophage migration induced by
cobalt is due to both the increased cell spreading and the enhanced
podosome formation.
We also found that the molecular mechanisms through which
cobalt regulated podosome adhesion and reduced migration,
involves the formation of ROS (Fig. 7). Both Co2+ and CoNPs were
shown to promote generation of the oxidative stress and increase
ROS levels in vitro [42,43]. ROS is generated as a by-product during
cellular oxidative metabolism, although its overproduction
enhances cellular oxidative stress, transforming cells so they are
unable to maintain normal physiological functions [44,45]. ROS
are also the key signalling molecules during the progression of
inflammatory disorders [46], by modulating the production of
inflammatory chemokines and expression of leukocyte adhesion
receptors to accumulate circulating monocytes at affected sites
[46]. Oxygen radicals produced by local macrophages may further
facilitate macrophage accumulation and their activation, resulting
in prolonged inflammation. Our findings indicate that the mecha-
nism behind the retention of infiltrated macrophages at the
inflamed sites is mediated by ROS through regulating the
cytoskeleton reorganization.
The cytoskeleton reorganization in presence of ROS is driven by
the ability of ROS to induce reversible oxidation of proteins, which
involves direct modification of protein kinases and transcription
factors [47]. Major regulators of macrophage motility and
cytoskeleton organization are influenced by Rho family GTPase[48–50], F-actin regulation pathways [51] and tyrosine phosphory-
lation [52,53]. The Rho family of GTPases play critical roles in cell
motility by affecting actin organization and microtubule dynamics,
myosin activity, and cell–ECM and cell–cell interactions [54]. In
this study, we showed for the first time that cobalt-induced ROS
formation acts as an upstream regulator to directly inactivate the
RhoA, leading to reorganization of macrophage cytoskeleton and
impaired cell migration (Fig. 7F–K). Small GTPase Rho is known
to stimulate stress fiber formation and hamper the cell migration
in many types of cells [55]. It is even reported that inactivation
of Rho in transformed fibroblasts by dominant negative RhoA or
the C3 exoenzyme would disrupt podosome structure [56], but
also that podosome formation in Src-transformed fibroblasts could
be promoted by limiting Rho activation [57]. In addition, it was
recently revealed that podosome disassembly is associated with
the activation of Rho and blockade of RhoA signalling could pro-
mote actin core assembly and podosome formation in macro-
phages [58].
Underlying mechanisms through which biomaterials-induced
ROS formation modulates macrophage behaviour are of consider-
able importance. Despite emerging advances in materials science,
biomaterials do not behave like native biological components
and frequently incite adverse tissue reactions, which may lead to
ultimate failure of the implants. Therefore accurate and facile
approaches for screening and evaluating the biocompatibility of
biomaterials are of critical interest, especially understanding the
cellular behaviour of macrophages because of their decisive role
in the long term survival of implanted biomaterials in addition to
orchestrating inflammatory processes.
Over recent years, the use of MoM total hip replacement is in a
drastic decline due to CoCr-related issues. However, implants con-
taining CoCr alloys are still being widely utilized, such as in dental
prosthesis and modular heads in MoP couplings. Significant
increase in the amount of metal ion released into the saliva of
patients with dental metallic materials has been reported [59].
Modular taper junctions allow for patient-specific fitting of
implants. However, numerous retrieval studies have recently doc-
umented the adverse tissue reactions and pseudotumor formation
adjacent to taper junctions in hip implants [5,7], which are clini-
cally and histologically similar to ALTRs previously seen in failed
MoM bearing. The etiology of this soft-tissue damage is also linked
to release of metal ions and debris from the modular taper junc-
tions. Therefore, further investigation is required to elucidate these
different, yet similar, exposure scenarios. More importantly, a com-
prehensive biological evaluation of metal exposure is necessary
due to the potentially destructive nature of these adverse
reactions.
We acknowledge several limitations in this study. Although we
have provided an explicit demonstration of the effect of cobalt on
macrophage migration behaviour via a range of in vivo and in vitro
techniques, it is still unknown whether macrophage accumulation
around MoM hips is caused by a defective migratory ability. A
refined animal study with in vivo tracking of macrophage recruit-
ment would facilitate further investigation and yield improved
understanding. Using commercially available nanoparticles in
place of cobalt and chromium wear debris allowed us to decipher
the individual role of the two primary elements in the cellular
response. Possible synergistic effect of these two metals is of
importance and should be addressed in the future studies. Both
human U937 cell line and primary murine macrophages were used
for data consistency, instead of primary human macrophages.
These cellular models excluded the influence of variability in cells
from different human donors, as have been used as in vitro cell
models to study responses to orthopaedic wear products including
bone cement, polyethylene, ceramic, metal particles, as well as
metal ions [32,60–62]. Findings of our current study, can help us
J. Xu et al. / Acta Biomaterialia 72 (2018) 434–446 445design further investigations using primary human cells to charac-
terize individual patient’s responses to the wear debris.5. Conclusion
Our study identified a new downstream effect of cobalt-induced
ROS production and reduced RhoA expression in modulating
macrophage migration and cytoskeleton organization. The effects
of this signalling cascade lead to an enhancement in macrophage
spreading, adhesion and inhibition of migration, which could
induce a prolonged immune cell retention thereby propagating
the chronic inflammation. The increased podosome formation in
macrophages is also associated with enhanced activation of
MMP9 and associated increased matrix degradation. The identifi-
cation of this new mechanism through which cobalt, but not chro-
mium, ions and nanoparticles induce macrophage retention at
inflammatory sites provides a novel insight into the metal-
associated periprosthetic tissue lesions.
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